BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 5033668)

  • 1. Immune reactive factor IX in acquired factor IX deficiency.
    Lechner K
    Thromb Diath Haemorrh; 1972 Feb; 27(1):19-24. PubMed ID: 5033668
    [No Abstract]   [Full Text] [Related]  

  • 2. Electroimmunoassay of factor IX in patients with liver damage and vitamin K unresponsive coagulation disorder.
    Girolami A; Burul A; Cappellato G; Dal Bo Zanon R
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(1):65-71. PubMed ID: 88391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical significance of factor IX analysis in blood coagulation tests].
    Kakishita E; Nishida Y
    Nihon Rinsho; 1989 Dec; 48 Suppl():834-6. PubMed ID: 2622013
    [No Abstract]   [Full Text] [Related]  

  • 4. Variants of haemophilia B.
    Elödi S; Puskás E
    Thromb Diath Haemorrh; 1972 Dec; 28(3):489-95. PubMed ID: 4675270
    [No Abstract]   [Full Text] [Related]  

  • 5. [Presence of inactive factor ix in variants of hemophilia, type B, and in carriers of hemophilia B].
    Elodi S
    Minerva Med; 1975 Jun; 66(42):2037-43. PubMed ID: 1138213
    [No Abstract]   [Full Text] [Related]  

  • 6. Factor IX Zutphen. A genetic variant of blood coagulation factor IX with an abnormally high molecular weight.
    Bertina RM; Van Der Linden IK
    J Lab Clin Med; 1982 Nov; 100(5):695-704. PubMed ID: 7130828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Factor IX in liver diseases].
    Balkuv S; Oktay E; Ulutin ON; Barlas O
    Turk Tip Cemiy Mecm; 1967 Mar; 33(3):133-7. PubMed ID: 6039950
    [No Abstract]   [Full Text] [Related]  

  • 8. [Preparation of factor IX deficient plasma by immunoadsorption using monoclonal antibody (3A6) to factor IX and its application].
    Nishimura T; Ohkubo Y; Nishino M; Sakai T; Sawai J; Tanaka I; Takamiya O; Yoshioka A
    Rinsho Byori; 1986 Apr; 34(4):469-74. PubMed ID: 3528584
    [No Abstract]   [Full Text] [Related]  

  • 9. Trypsin clotting time (K-test) in hemophilia A and in hemophilia B1.
    Girolami A; Dal Bo Zanon R; Procidano M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(6):863-71. PubMed ID: 6176512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new drug form of blood coagulation factor IX: red blood cell-entrapped factor IX.
    Sinauridze EI; Vuimo TA; Kulikova EV; Shmyrev II; Ataullakhanov FI
    Med Sci Monit; 2010 Oct; 16(10):PI19-26. PubMed ID: 20885362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proceedings: Electroimmunoassay of human coagulation factor IX in the detection of variants of haemophilia B.
    Orstavik K; Osterud B
    Thromb Diath Haemorrh; 1975 Sep; 34(1):322-3. PubMed ID: 1188733
    [No Abstract]   [Full Text] [Related]  

  • 12. Factor IX of the blood coagulation system: a review.
    Taran LD
    Biochemistry (Mosc); 1997 Jul; 62(7):685-93. PubMed ID: 9331959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performances of an artificial reagent for the one-stage factor IX assay.
    Meunier L; Allain JP; Frommel D
    Thromb Diath Haemorrh; 1975 Jun; 33(3):547-52. PubMed ID: 1154311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The genetic heterogeneity of hemophilia B.
    Brown PE; Hougie C; Roberts HR
    N Engl J Med; 1970 Jul; 283(2):61-4. PubMed ID: 5420360
    [No Abstract]   [Full Text] [Related]  

  • 15. Congenital bleeding disorders of the vitamin K-dependent clotting factors.
    Girolami A; Scandellari R; Scapin M; Vettore S
    Vitam Horm; 2008; 78():281-374. PubMed ID: 18374200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Factor IX and factor IX inhibitor].
    Higasa S
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():647-50. PubMed ID: 15658413
    [No Abstract]   [Full Text] [Related]  

  • 17. [Action of venom of the central Asian cobra (Naja oxiana eich.) on the blood-coagulating system].
    Mitel'man LSh
    Biull Eksp Biol Med; 1966 Sep; 62(9):69-71. PubMed ID: 6012423
    [No Abstract]   [Full Text] [Related]  

  • 18. Factor IX alloantibodies shorten the bovine thromboplastin coagulation time of normal human plasma.
    Orstavik KH
    Thromb Haemost; 1981 Dec; 46(4):684-6. PubMed ID: 7330818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor IX-inhibitors. Report of two cases and a study of the biological, chemical and immunological properties of the inhibitors.
    Lechner K
    Thromb Diath Haemorrh; 1971 Jun; 25(3):447-59. PubMed ID: 5561957
    [No Abstract]   [Full Text] [Related]  

  • 20. Acquired factor IX inhibitor in a patient with Christmas disease: case report.
    Riyat MS; Kasili EG; Omondi BE
    East Afr Med J; 1984 Feb; 61(2):159-62. PubMed ID: 6468323
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.